GPCR STRUCTURE THERAPEUTICS

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in September.

Cantor Global Healthcare Conference
 Format:Fireside chat and 1x1 meetings
 Date/time:Wednesday, September 3 at 3:55 p.m. ET
 Location:New York, NY
   


Morgan Stanley 23rd Annual Global Healthcare Conference

 Format:Fireside chat and 1x1 meetings
 Date/time:Wednesday, September 10 at 10:45 a.m. ET
 Location:New York, NY
   

The live and archived webcasts will be accessible from the company’s website at and replays will be available for 90 days.

About Structure Therapeutics 

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit .

Investors:

Danielle Keatley

Structure Therapeutics Inc.

Media:

Dan Budwick

1AB



EN
02/09/2025

Underlying

GPCRSTRUCTURE THERAPEUTICS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRUCTURE THERAPEUTICS

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.52
WCC WESCO Internati...
VIAV Viavi Solutions... ... (+44)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

WCC WESCO INTERNATIONAL INC.
VIAV VIAVI SOLUTIONS INC
ROG ROGERS CORPORATION
PBYI PUMA BIOTECHNOLOGY INC.
OMCL OMNICELL INC.
HII HUNTINGTON INGALLS INDUSTRIES INC.
GPRK GEOPARK
FORM FORMFACTOR INC.
CALX CALIX NETWORKS
AME AMETEK INC.
AVNW AVIAT NETWORKS
EFR ENERGY FUELS
CAH CARDINAL HEALTH INC.
CMCO COLUMBUS MCKINNON CORPORATION
ORN ORION GROUP HOLDINGS
CHRW C.H. ROBINSON WORLDWIDE INC.
JBSS JOHN B. SANFILIPPO & SON INC.
LAUR LAUREATE EDUCATION INC. CLASS A
OSW ONESPAWORLD HOLDINGS (A)
FOX FOX CORPORATION CLASS B
AEYE AUDIOEYE INC
REEMF RARE ELEMENT RESOURCES
GCI GANNETT CO. INC.
CMPR CIMPRESS PLC
TT TRANE TECHNOLOGIES PLC
SOPH SOPHIA GENETICS SA
ROIV ROIVANT SCIENCES LTD
MCW MISTER CAR WASH INC
PPTA PERPETUA RESOURCES CORP
CRML CLAL INDUSTRIES & BEVERAGES LTD
FTAI FORTRESS TRANSN & INFRAS INVS LLC
NAMS NEWAMSTERDAM PHARMA COMPANY B.V.
GPCR STRUCTURE THERAPEUTICS
LAES SEALSQ CORP
NB NIOCORP DEVELOPMENTS LTD.
FTK FLOTEK INDUSTRIES INC.
IDR IDAHO STRATEGIC RESOURCES INC
ESEA EUROSEAS LTD
CDTX CIDARA THERAPEUTICS INC.
PRM PERIMETER SOLUTIONS INC
MAZE MAZE THERAPEUTICS INC
FRGE FORGE GLOBAL HLDGS INC
LTBR LIGHTBRIDGE CORP
GSAT GLOBALSTAR INC.
10/31/25 October 31, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.52
BKD Brookdale Senio...
XENE Xenon Pharmaceu... ... (+57)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

BKD BROOKDALE SENIOR LIVING INC.
XENE XENON PHARMACEUTICALS INC
SEDG SOLAREDGE TECHNOLOGIES INC.
RUN SUNRUN INC.
LTRX LANTRONIX INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
LAKE LAKELAND INDUSTRIES INC.
CEVA CEVA INC.
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ALB ALBEMARLE CORPORATION
EFR ENERGY FUELS
RELL RICHARDSON ELECTRONICS LTD.
NTLA INTELLIA THERAPEUTICS INC.
UAMY UNITED STATES ANTIMONY CORP.
BOMN BOSTON OMAHA
ICL ICL GROUP LTD.
LWLG LIGHTWAVE LOGIC
IMTX IMMATICS N V (A)
ARRY ARRAY TECHNOLOGIES
IMVT IMMUNOVANT
RLAY RELAY THERAPEUTICS
FLUX FLUX POWER HOLDINGS
GLUE MONTE ROSA THERAPEUTICS INC
ASTS AST SPACEMOBILE INC
TRDA ENTRADA THERAPEUTICS INC
JANX JANUX THERAPEUTICS INC
APLD APPLIED BLOCKCHAIN INC
IE IVANHOE ELECTRIC INC
NUVL NUVALENT INC
COHR COHERENT CORP
CRML CLAL INDUSTRIES & BEVERAGES LTD
GPCR STRUCTURE THERAPEUTICS
OCS OCULIS HOLDING AG
LAES SEALSQ CORP
NB NIOCORP DEVELOPMENTS LTD.
METBV FORTREA HOLDINGS INC.
FTREV SAGIMET BIOSCIENCES INC
SGMT BYRNA TECHNOLOGIES INC
BYRN ENGENE HOLDINGS INC
ENGN SPYRE THERAPEUTICS INC.
SYRE NEUROGENE INC
NGNE RAMACO RESOURCES INC.
METC TOYO CO LTD
TOYO SERVE ROBOTICS INC
SERV UPSTREAM BIO INC
UPB CIDARA THERAPEUTICS INC.
CDTX AMERICAN BATTERY TECHNOLOGY COMPANY
ABAT TVARDI THERAPEUTICS INC
TVRD USA RARE EARTH INC
USAR HYCROFT MINING HOLDING CORPORATION
HYMC CATALYST PERINI STRATEGIC INCOM ORD
CSIOX CHARGEPOINT HOLDINGS INC.
CHPT KULR TECHNOLOGY GROUP INC.
KULR GRAFTECH INTERNATIONAL LTD.
EAF GLOBALSTAR INC.
GSAT INHIBRX BIOSCIENCES INC.
INBX KON TUM CONSTRUCTION MATERIALS ORD
10/10/25 October 10, 2025 1 EN
 PRESS RELEASE
Free
GPCR STRUCTURE THERA...

Structure Therapeutics to Participate in Two Upcoming Healthcare Inves...

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in September. Cantor Global Healthcare Conference Format:Fireside chat and 1x1 meetings Date/time:Wednesday, September 3 at 3:55 p.m. ET Location:New York, NY   Morgan Stanley 2...

September 2, 2025 1 EN
 PRESS RELEASE
Free
GPCR STRUCTURE THERA...

Structure Therapeutics Reports Second Quarter 2025 Financial Results a...

Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights Topline data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for year-end 2025 readouts Aleniglipron clinical development program expanded to optimize competitive positioning and Phase 3 program Oral small molecule amylin receptor agonist (ACCG-2671) Phase 1 initiation anticipated by year-end 2025 Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected ...

August 6, 2025 1 EN
 PRESS RELEASE
Free
GPCR STRUCTURE THERA...

Structure Therapeutics Announces Two Late-Breaking Poster Presentation...

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671 SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions, being held from June 20-23 in Chicag...

June 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch